HSA
- Status: likely_approved
🇸🇬 Capozide 25/15 in Singapore
Capozide 25/15 (CAPTOPRIL) regulatory status in Singapore.
Marketing authorisations
HSA
- Status: likely_approved
HSA
- Status: likely_approved
HSA
- Status: likely_approved
HSA
- Status: likely_approved
Capozide 25/15 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Singapore
Frequently asked questions
Is Capozide 25/15 approved in Singapore?
Yes. HSA has authorised it; HSA has authorised it; HSA has authorised it.
Who is the marketing authorisation holder for Capozide 25/15 in Singapore?
Aarxion Anda Hlding is the originator. The local marketing authorisation holder may differ — check the official source linked above.